About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
AbbVie Inc. (ABBV): Insider Trades and Fund Holdings
In the past 12 months, AbbVie Inc. insiders reported no open-market purchases and 1 sale worth $8.18M; 0 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 15, 2026NewsCompany reported: Executive or director change
- Oct 5, 2026NewsCompany reported: Quarterly or annual results
- Sep 14, 2026CongressRep. Pete Sessions sell $15K–$50K
- Aug 14, 2026Insider saleEVP Nicholas Donoghoe sold $8.2 million
- Aug 14, 2026Planned saleNICHOLAS DONOGHOE (officer) filed notice to sell about $8.2 million around Aug 14, 2026
- Jul 31, 2026NewsCompany reported: Quarterly or annual results
- Jun 30, 2026FundBridgewater Associates cut 61% in Q2 2026 (13F filed Aug 14, 2026)
- May 5, 2026CongressRep. Josh Gottheimer sell $1K–$15K (joint)
- Dec 18, 2025CongressRep. Julie Johnson sell $1K–$15K (joint)
- Dec 8, 2025CongressRep. Julia Letlow sell $1K–$15K
- Nov 13, 2025CongressRep. Julie Johnson partial sell $1K–$15K (joint)
- Oct 31, 2025CongressRep. Lisa C. McClain sell $1K–$15K (spouse)
- Oct 30, 2025CongressRep. Lisa C. McClain sell $1K–$15K (spouse)
- Oct 30, 2025CongressRep. Lisa C. McClain buy $1K–$15K (spouse)
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Aug 18, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 18 | Nicholas DonoghoeEVP | ▼ SELL | $8.18M |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Nicholas Donoghoe | EVP | 0 | $0 | 1 | $8.18M |
Trades by members of Congress
Reported under the STOCK Act. Amounts are ranges from the form. All Congress trades →
| Filed | Member | Type | Amount |
|---|---|---|---|
| Sep 18 | Rep. Pete SessionsR-TX-17 | ▼ SELL | $15K–$50K |
| Jun 3 | Rep. Josh GottheimerD-NJ-5 | ▼ SELL | $1K–$15K |
| Jan 15 | Rep. Julie JohnsonD-TX-32 | ▼ SELL | $1K–$15K |
| Jan 13 | Rep. Julia LetlowR-LA-5 | ▼ SELL | $1K–$15K |
| Jan 13 | Rep. Julia LetlowR-LA-5 | ▲ BUY | $1K–$15K |
| Jan 13 | Rep. Julia LetlowR-LA-5 | ▼ SELL | $1K–$15K |
| Dec 11 | Rep. Julie JohnsonD-TX-32 | ▼ PARTIAL SELL | $1K–$15K |
| Nov 21 | Rep. Lisa C. McClainR-MI-9 | ▼ SELL | $1K–$15K |
| Nov 21 | Rep. Lisa C. McClainR-MI-9 | ▼ SELL | $1K–$15K |
| Nov 21 | Rep. Lisa C. McClainR-MI-9 | ▲ BUY | $1K–$15K |
Buybacks and executive pay
AbbVie Inc. spent $980 million buying back its own shares in 2025.
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
Tracked funds that report ABBV
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Bridgewater Associates | 11,775 | $2.96M | ▼ −61.2% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →